Header Logo

Connection

Nirav Shah to Clinical Trials, Phase III as Topic

Back to Details
This is a "connection" page, showing publications Nirav Shah has written about Clinical Trials, Phase III as Topic.
Nirav Shah
Connection Strength
0.049
Clinical Trials, Phase III as Topic
  1. BRUIN MCL-321: phase III study of pirtobrutinib versus investigator choice of BTK?inhibitor in BTK?inhibitor?naive mantle cell lymphoma. Future Oncol. 2022 Nov; 18(36):3961-3969.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.